JP2024538091A5 - - Google Patents
Info
- Publication number
- JP2024538091A5 JP2024538091A5 JP2024522237A JP2024522237A JP2024538091A5 JP 2024538091 A5 JP2024538091 A5 JP 2024538091A5 JP 2024522237 A JP2024522237 A JP 2024522237A JP 2024522237 A JP2024522237 A JP 2024522237A JP 2024538091 A5 JP2024538091 A5 JP 2024538091A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- approximately
- arginine
- poloxamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163256432P | 2021-10-15 | 2021-10-15 | |
| US63/256,432 | 2021-10-15 | ||
| PCT/US2022/078097 WO2023064886A1 (en) | 2021-10-15 | 2022-10-14 | Formulations of factor viii chimeric proteins and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024538091A JP2024538091A (ja) | 2024-10-18 |
| JP2024538091A5 true JP2024538091A5 (cg-RX-API-DMAC7.html) | 2025-10-21 |
Family
ID=84362012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522237A Pending JP2024538091A (ja) | 2021-10-15 | 2022-10-14 | 第ｖｉｉｉ因子キメラタンパク質の製剤およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240358800A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4415693B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024538091A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240082408A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118103034A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022366974A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3229979A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2024004211A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL311969A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024004494A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202334244A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023064886A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2124690C (en) * | 1992-10-02 | 2007-09-11 | Thomas Osterberg | Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| PL3793588T3 (pl) * | 2018-05-18 | 2025-09-01 | Bioverativ Therapeutics Inc. | Sposoby leczenia hemofilii a |
-
2022
- 2022-10-14 CN CN202280069172.7A patent/CN118103034A/zh active Pending
- 2022-10-14 JP JP2024522237A patent/JP2024538091A/ja active Pending
- 2022-10-14 TW TW111139016A patent/TW202334244A/zh unknown
- 2022-10-14 KR KR1020247015817A patent/KR20240082408A/ko active Pending
- 2022-10-14 EP EP22813008.4A patent/EP4415693B1/en active Active
- 2022-10-14 WO PCT/US2022/078097 patent/WO2023064886A1/en not_active Ceased
- 2022-10-14 CA CA3229979A patent/CA3229979A1/en active Pending
- 2022-10-14 AU AU2022366974A patent/AU2022366974A1/en active Pending
- 2022-10-14 MX MX2024004494A patent/MX2024004494A/es unknown
- 2022-10-14 IL IL311969A patent/IL311969A/en unknown
-
2024
- 2024-04-04 CO CONC2024/0004211A patent/CO2024004211A2/es unknown
- 2024-04-10 US US18/632,038 patent/US20240358800A1/en active Pending